Professor Lars Fugger and his team have been using genetics to explore ways of producing new treatments for autoimmune diseases, but with significantly fewer side effects.
Many of the current treatments for autoimmune diseases, which include multiple sclerosis, rheumatoid arthritis and inflammatory bowel disease, involve deliberately weakening the body’s immune system. This leaves patients at greater risk of developing other opportunistic illnesses.
Study paves the way for new autoimmune disease treatments with fewer side effects
3 November 2016
New research from our Department has raised the possibility of minimising the side effects of treatment for patients with autoimmune diseases, such as multiple sclerosis and inflammatory bowel disease.
